As COVID-19 impacts the world, StemVax Therapeutics continues to be committed to making a difference in brain cancer patients' lives by maintaining focus on developing a highly effective vaccine for Glioblastoma (GBM). We are also committed to working hard to support all healthcare professionals, patients, and communities here in the U.S. and globally. We are learning so much more about COVID-19 recently than ever before. We seek to utilize our expertise to participate in the development of novel diagnostic and therapeutic tools to address COVID-19 and other viruses that contribute to seasonal flu outbreaks.
Copyright © 2019 Stemvax.com - All Rights Reserved.